002919 名臣健康
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.3829.0833.39118.89116.750
总资产报酬率 ROA (%)3.5195.5902.29414.43512.952
投入资产回报率 ROIC (%)4.5117.3832.89717.00513.738

边际利润分析
销售毛利率 (%)65.72060.26752.50050.38542.450
营业利润率 (%)13.3423.538-0.57717.03215.450
息税前利润/营业总收入 (%)13.2093.5261.10217.09015.457
净利润/营业总收入 (%)12.3814.2972.68617.93915.023

收益指标分析
经营活动净收益/利润总额(%)116.285167.553-117.50290.560104.277
价值变动净收益/利润总额(%)0.0000.1464.88817.3027.704
营业外收支净额/利润总额(%)-2.153-2.303135.7940.596-0.372

偿债能力分析
流动比率 (X)2.2091.9641.4423.4773.005
速动比率 (X)1.6671.4871.0102.7892.382
资产负债率 (%)32.80736.43140.52021.90325.446
带息债务/全部投入资本 (%)13.34814.57713.5725.989--
股东权益/带息债务 (%)636.799566.783588.5161,530.736769.736
股东权益/负债合计 (%)204.817174.490146.793356.558292.988
利息保障倍数 (X)88.81551.930-2.156-386.840240.961

营运能力分析
应收账款周转天数 (天)89.51654.50670.63196.2290.000
存货周转天数 (天)154.356110.557129.989131.8700.000